Amarin Corp. PLC hasn't even sought European Medicines Agency (EMA) approval for its purified fish oil therapy Vascepa (icosapent ethyl) to treat hypertriglyceridemia, but already the drug has won an endorsement from the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) in new dyslipidemia treatment guidelines presented on 2 September at the ESC Congress in Paris.
The ESC/EAS guidelines now state that doctors should consider prescribing Vascepa for patients who have high triglyceride levels despite treatments...